GAMMA Investing LLC trimmed its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 37.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,691 shares of the company’s stock after selling 1,024 shares during the period. GAMMA Investing LLC’s holdings in Avantor were worth $36,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of AVTR. UMB Bank n.a. acquired a new position in shares of Avantor in the 3rd quarter valued at $49,000. Nisa Investment Advisors LLC raised its stake in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after acquiring an additional 3,700 shares during the last quarter. Quarry LP boosted its holdings in shares of Avantor by 4,489.1% in the 2nd quarter. Quarry LP now owns 6,333 shares of the company’s stock valued at $134,000 after buying an additional 6,195 shares during the period. Finally, ORG Wealth Partners LLC acquired a new stake in shares of Avantor during the 3rd quarter worth approximately $139,000. 95.08% of the stock is owned by institutional investors and hedge funds.
Avantor Trading Down 1.4 %
AVTR stock opened at $21.71 on Wednesday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The stock has a market capitalization of $14.78 billion, a price-to-earnings ratio of 47.20, a P/E/G ratio of 2.75 and a beta of 1.28. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The business has a fifty day moving average price of $21.49 and a 200 day moving average price of $23.36.
Analyst Ratings Changes
View Our Latest Research Report on Avantor
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
See Also
- Five stocks we like better than Avantor
- Want to Profit on the Downtrend? Downtrends, Explained.
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- What does consumer price index measure?
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- What is the Australian Securities Exchange (ASX)
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.